Physician groups, hospitals and health systems of all sizes must prioritize what cost-cutting strategies will deliver the most value, both in the short and long term.
What could rein in rising drug prices? Modern Healthcare sought to find out.
Along with the rest of the industry, Modern Healthcare is eager to hear what President Donald Trump has to say about drug prices. But that's not all we are watching this week.
New research suggests policymakers need to directly address prices rather than focusing on value-based care.
The California attorney general's allegations that Sutter Health inflates healthcare prices could guide other states that aim to break up highly concentrated markets.
Health insurers and pharmaceutical companies are pointing fingers at each other over the rising cost of prescription drugs as scrutiny of drug spending intensifies.
A long-standing obsession with waste and overutilization is slowly giving way to a greater appreciation for how entrenched poverty, a tattered safety net and exorbitant prices may explain why we spend so much more than other countries.
About 30% of the $3.4 trillion spent on healthcare services each year is thought to be unnecessary or wasteful. Health systems, supported by the transition to value-based payment, are changing how they practice to try to tackle the problem.
The hospital systems buying physician practices say vertical integration will facilitate care coordination and lower costs. Where's the evidence?
Federal lawmakers soon may have financial justification for funding cost-sharing reduction payments for insurers as well as reinsurance, when a new government report shows CSRs will save the government $32 billion if they're funded for the next three years.
Following a financial turnaround in its operations in 2017, Chicago-based Health Care Service Corp. is anxious to promote fresh ideas in containing patient-care costs. It will budget $1.5 billion over the next three years on affordability initatives.
It's too early to say the era of cost control, which stretched roughly from 2010 to 2016, is over. But as the latest CMS cost projections suggest, the U.S. appears headed into another period when healthcare spending routinely exceeds the economy's overall rate of growth.